| Project/Area Number |
22500683
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Applied health science
|
|---|
| Research Institution | Kobe Gakuin University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
NAKAMOTO Kazuo 神戸学院大学, 薬学部, 講師 (30432636)
FUJITA Wakako (HAMABE Wakako) 神戸学院大学, 薬学部, 講師 (30382328)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2012: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2011: ¥520,000 (Direct Cost: ¥400,000、Indirect Cost: ¥120,000)
Fiscal Year 2010: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
|
|---|
| Keywords | 生活習慣病 / orexin 神経 / グルコース受容体 / 脳卒中 / 血糖値 / オレキシン神経 / 脳虚血ストレス / 糖代謝機能 / インスリン / オレキシン-A / オレキシン受容体 / 虚血後耐糖能異常 / 視床下部 |
|---|
| Research Abstract |
In this study, we determined the effects of intra-hypothalamic administration of orexin-A on the development of post-ischemic glucose intolerance, including changes in insulin signaling and ischemic neuronal damage.In conclusion, regulation of post-ischemic glucose intolerance by intra-hypothalamic administration of orexin-A significantly suppressed cerebral ischemic neuronal damage. These findings provide some insight into the therapeutic effectiveness of the use of this endogenous neuropeptide. These results from the present study may be helpful for the development of new agents and strategies for clinical treatment of cerebral stroke.
|
